Characterization of the novel alleles: HLA-A*01:305, HLA-B*58:120, HLA-C*04:428Q and HLA-C*05:01:56. 2022

Julia Kalser, and Claudia Hobel-Kleisch, and Johannes Weinberger, and Christof Jungbauer, and Wolfgang R Mayr
Histocompatibility and Immunogenetics Laboratory, Austrian Red Cross, Blood Service for Vienna, Vienna, Austria.

Four new HLA class I alleles were characterized by next-generation sequencing and haplotypes determined.

UI MeSH Term Description Entries
D005787 Gene Frequency The proportion of one particular in the total of all ALLELES for one genetic locus in a breeding POPULATION. Allele Frequency,Genetic Equilibrium,Equilibrium, Genetic,Allele Frequencies,Frequencies, Allele,Frequencies, Gene,Frequency, Allele,Frequency, Gene,Gene Frequencies
D006239 Haplotypes The genetic constitution of individuals with respect to one member of a pair of allelic genes, or sets of genes that are closely linked and tend to be inherited together such as those of the MAJOR HISTOCOMPATIBILITY COMPLEX. Haplotype
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000483 Alleles Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product. Allelomorphs,Allele,Allelomorph
D015234 HLA-A Antigens Polymorphic class I human histocompatibility (HLA) surface antigens present on almost all nucleated cells. At least 20 antigens have been identified which are encoded by the A locus of multiple alleles on chromosome 6. They serve as targets for T-cell cytolytic responses and are involved with acceptance or rejection of tissue/organ grafts. Antigens, HLA-A,HLA-A,Antigens, HLA A,HLA A Antigens
D015235 HLA-B Antigens Class I human histocompatibility (HLA) surface antigens encoded by more than 30 detectable alleles on locus B of the HLA complex, the most polymorphic of all the HLA specificities. Several of these antigens (e.g., HLA-B27, -B7, -B8) are strongly associated with predisposition to rheumatoid and other autoimmune disorders. Like other class I HLA determinants, they are involved in the cellular immune reactivity of cytolytic T lymphocytes. Antigens, HLA-B,HLA-B Antigen,HLA-B,Antigen, HLA-B,Antigens, HLA B,HLA B Antigen,HLA B Antigens
D015236 HLA-C Antigens Class I human histocompatibility (HLA) antigens encoded by a small cluster of structural genes at the C locus on chromosome 6. They have significantly lower immunogenicity than the HLA-A and -B determinants and are therefore of minor importance in donor/recipient crossmatching. Their primary role is their high-risk association with certain disease manifestations (e.g., spondylarthritis, psoriasis, multiple myeloma). Antigens, HLA-C,HLA-C,Antigens, HLA C,HLA C Antigens
D059014 High-Throughput Nucleotide Sequencing Techniques of nucleotide sequence analysis that increase the range, complexity, sensitivity, and accuracy of results by greatly increasing the scale of operations and thus the number of nucleotides, and the number of copies of each nucleotide sequenced. The sequencing may be done by analysis of the synthesis or ligation products, hybridization to preexisting sequences, etc. High-Throughput Sequencing,Illumina Sequencing,Ion Proton Sequencing,Ion Torrent Sequencing,Next-Generation Sequencing,Deep Sequencing,High-Throughput DNA Sequencing,High-Throughput RNA Sequencing,Massively-Parallel Sequencing,Pyrosequencing,DNA Sequencing, High-Throughput,High Throughput DNA Sequencing,High Throughput Nucleotide Sequencing,High Throughput RNA Sequencing,High Throughput Sequencing,Massively Parallel Sequencing,Next Generation Sequencing,Nucleotide Sequencing, High-Throughput,RNA Sequencing, High-Throughput,Sequencing, Deep,Sequencing, High-Throughput,Sequencing, High-Throughput DNA,Sequencing, High-Throughput Nucleotide,Sequencing, High-Throughput RNA,Sequencing, Illumina,Sequencing, Ion Proton,Sequencing, Ion Torrent,Sequencing, Massively-Parallel,Sequencing, Next-Generation

Related Publications

Julia Kalser, and Claudia Hobel-Kleisch, and Johannes Weinberger, and Christof Jungbauer, and Wolfgang R Mayr
July 2021, HLA,
Julia Kalser, and Claudia Hobel-Kleisch, and Johannes Weinberger, and Christof Jungbauer, and Wolfgang R Mayr
September 2023, HLA,
Julia Kalser, and Claudia Hobel-Kleisch, and Johannes Weinberger, and Christof Jungbauer, and Wolfgang R Mayr
March 2012, Tissue antigens,
Julia Kalser, and Claudia Hobel-Kleisch, and Johannes Weinberger, and Christof Jungbauer, and Wolfgang R Mayr
April 2017, HLA,
Julia Kalser, and Claudia Hobel-Kleisch, and Johannes Weinberger, and Christof Jungbauer, and Wolfgang R Mayr
August 2021, HLA,
Julia Kalser, and Claudia Hobel-Kleisch, and Johannes Weinberger, and Christof Jungbauer, and Wolfgang R Mayr
August 2019, HLA,
Julia Kalser, and Claudia Hobel-Kleisch, and Johannes Weinberger, and Christof Jungbauer, and Wolfgang R Mayr
June 2021, HLA,
Julia Kalser, and Claudia Hobel-Kleisch, and Johannes Weinberger, and Christof Jungbauer, and Wolfgang R Mayr
January 2023, HLA,
Julia Kalser, and Claudia Hobel-Kleisch, and Johannes Weinberger, and Christof Jungbauer, and Wolfgang R Mayr
July 2023, HLA,
Julia Kalser, and Claudia Hobel-Kleisch, and Johannes Weinberger, and Christof Jungbauer, and Wolfgang R Mayr
October 2023, HLA,
Copied contents to your clipboard!